I won't say that pancreatic is the WORST for survival rate, but at 12% (mentioned at a pancan.org walk event), it's at least pretty awful. There's lots of room for improvement, and something that enables immune systems to "see" and respond could be good. And may become a treatment strategy for other cancers.